Hyalual brand, product owner Diaco Biofarmaceutici S.r.l
Xela Rederm
Injectable implant based on hyaluronic acid in a syringe, combined with succinic acid. Three concentrations of hyaluronic acid: 1.1%, 1.8% and 2.2%.
- HSA register
- Class D medical device, MDPR260401X0003
- Registered
- 1 April 2026, registrant GLO Pharma Pte Ltd
- Product owner
- Diaco Biofarmaceutici S.r.l (register)
- Supplied to
- Registered medical practitioners only



